Tandem Diabetes Care, Inc. - Common Stock — Financial Statistics (NASDAQ:TNDM) | MetaTrader

Open full chart

News

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Abbott Laboratories (N

Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?

Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - Tandem Diabetes Care (NASDAQ:TNDM), Be

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say

Does TNDM Stock Still Deserve a Place in Your Portfolio?

NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?

Zacks.com featured highlights include Tandem, Dell and CNO Financial

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now